Gallery

Photo Tour
API Plant III

Manufacturing Site

State-of-the-art facility spread over 45,000 sq. m

Manufacturing Site

Dedicated blocks for FPP's, Bulk Drugs & Research

Stores

Over 3000 Sq. m for storage of RM/PM

Stores

ERP controlled material dispensing as per FIFO

Solid Dosage

2 tablet production lines with daily output of 5 million

Solid Dosage

2 capcule production lines with daily output of 2 million

Liquid Orals

2 liquid production lines & 1 suspension line

Liquid Orals

High speed automated line

Dry Powder

Automated line with daily output of .05 million bottle per day

Topicals

Non sterile production line with alu./lami & jar packing

API Plant

Bulk Drugs

Dedicated blocks for Anti Malarials, Vasodilator & Exipients

API Plant III

Bulk Drugs

Dedicated blocks for Anti Malarials, Vasodilator & Exipients

QA & QC Lab

State-of-the-art division with analytical instruments

QA & QC Lab

State-of-the-art division with analytical instruments

QA & QC Lab

State-of-the-art division with analytical instruments

R&D Center

DSIR Approved Center for API & FPP Development

R&D Center

Equipped with latest analytical instruments & pilot plant

R&D Center

cGMP Compliant with Class D maintenance

R&D Lab

Backed by highly trained scientists with proven credentials

Corporate Office

Headquartered in Mumbai, India

Corporate Office

Headquartered in Mumbai, India

Corporate Office

Headquartered in Mumbai, India

Copyrights ©2014: S Kant HEALTHCARE Ltd.